Analyze Diet
Veterinary microbiology1996; 51(1-2); 55-68; doi: 10.1016/0378-1135(96)00032-6

Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes.

Abstract: Equine herpesvirus type 2 (EHV-2), a member of the Gammaherpesvirinae subfamily, was studied in a two-phase respiratory disease complex of young foals as a predisposing factor for the secondary bacterial invasion of lungs with Rhodococcus equi (R. equi). Foals were immunized against EHV-2 on a farm where R. equi pneumonia regularly occurred during the last years. The immunizations were performed by using a subunit vaccine which selectively presents envelope glycoproteins of EHV-2 in a multimeric form of immunostimulating complexes (iscoms). The etiological role of EHV-2 was estimated by observing the occurrence of the respiratory disease complex in groups of foals immunized against the virus, in comparison to non-immunized controls. The immunization trials of young animals revealed that the iscom subunit vaccine formulation is able to overcome the interference of maternal antibodies. Active immunization of foals with a single dose of the iscoms provided a certain degree of protection, while two injections of iscoms yielded complete protection against the disease complex in the majority of the treated animals, by preventing the manifestation of R. equi pneumonia. The present findings strongly support the hypothesis that EHV-2 is a predisposing factor for the R. equi invasion of the respiratory tract. The EHV-2 iscom formulation provides highly specific and effective means to prevent the disease complex.
Publication Date: 1996-07-01 PubMed ID: 8828122DOI: 10.1016/0378-1135(96)00032-6Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigated the role of Equine herpesvirus type 2 (EHV-2) as a contributing factor to Rhodococcus equi pneumonia in foals and found that immunizing against EHV-2 could effectively prevent the disease complex.

Study Overview

The study delved into the respiratory disease complex in foals that was believed to be influenced by the presence of Equine herpesvirus type 2 (EHV-2). The research was centred around the claim that EHV-2 infection in foals made them more susceptible to a secondary bacterial invasion by Rhodococcus equi (R. equi), leading to the development of pneumonia.

Evaluating the Role of EHV-2

  • The researchers aimed to determine the role of EHV-2 by observing the occurrence of the respiratory disease complex in foals immunized against EHV-2 and comparing it to a control group of foals that were not immunized.
  • For the immunization, a subunit vaccine was used that selectively presents the envelope glycoproteins of EHV-2 in a multimeric form known as immunostimulating complexes (ISCOMs).

Immunization Findings

  • The vaccine trials showed that the ISCOM subunit formulation was capable of overcoming the interference from maternal antibodies in foals.
  • A single dose of the ISCOMs vaccine provided some degree of protection to the foals. However, two injections offered full protection against the respiratory disease complex to most of the treated animals.
  • Effectively, the symptom manifestation of R. equi pneumonia was prevented with the ISCOMs immunization, buttressing the idea that EHV-2 was a key contributing factor for the R. equi invasion of the respiratory tract in foals.

Conclusion

This study projects EHV-2 as a significant factor for susceptibility to R. equi pneumonia in young foals. The research findings also accentuate the potential of the EHV-2 ISCOM formulation as a highly specific and effective preventive measure against the disease.

Cite This Article

APA
Nordengrahn A, Rusvai M, Merza M, Ekström J, Morein B, Belák S. (1996). Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes. Vet Microbiol, 51(1-2), 55-68. https://doi.org/10.1016/0378-1135(96)00032-6

Publication

ISSN: 0378-1135
NlmUniqueID: 7705469
Country: Netherlands
Language: English
Volume: 51
Issue: 1-2
Pages: 55-68

Researcher Affiliations

Nordengrahn, A
  • Department of Virology, National Veterinary Institute, Uppsala, Sweden.
Rusvai, M
    Merza, M
      Ekström, J
        Morein, B
          Belák, S

            MeSH Terms

            • Actinomycetales Infections / etiology
            • Actinomycetales Infections / microbiology
            • Actinomycetales Infections / prevention & control
            • Actinomycetales Infections / veterinary
            • Animals
            • Herpesviridae / immunology
            • Herpesviridae Infections / complications
            • Herpesviridae Infections / microbiology
            • Herpesviridae Infections / prevention & control
            • Herpesviridae Infections / veterinary
            • Horse Diseases / immunology
            • Horse Diseases / microbiology
            • Horse Diseases / prevention & control
            • Horses
            • ISCOMs / administration & dosage
            • ISCOMs / chemistry
            • Mice
            • Mice, Inbred BALB C
            • Pilot Projects
            • Pneumonia, Bacterial / etiology
            • Pneumonia, Bacterial / microbiology
            • Pneumonia, Bacterial / prevention & control
            • Pneumonia, Bacterial / veterinary
            • Rhodococcus equi
            • Viral Vaccines / administration & dosage

            Citations

            This article has been cited 23 times.
            1. Asin J, Carvallo F, Gonzales-Viera OA, Macías-Rioseco M, Streitenberger N, Abdelrazek S, Crossley B, Pesavento PA, Uzal FA. Interstitial pneumonias of undetermined etiology in foals in California, 1990-2020. J Vet Diagn Invest 2026 Jan 29;:10406387251410524.
              doi: 10.1177/10406387251410524pubmed: 41612676google scholar: lookup
            2. Matos MC, Abrantes J, Lopes AM. Widespread presence of novel gammaherpesviruses in lagomorph species (Oryctolagus cuniculus, Lepus spp. and Ochotona alpina). Virol J 2025 Dec 24;22(1):398.
              doi: 10.1186/s12985-025-03000-5pubmed: 41444579google scholar: lookup
            3. James K, Chappell DE, Craig B, Pariseau C, Wright C, van Harreveld P, Barnum S, Pusterla N. Investigation of Selected Prevalence Factors Associated with EHV-2 and/or EHV-5 Infection in Horses with Acute Onset of Fever and Respiratory Signs. Viruses 2025 Apr 25;17(5).
              doi: 10.3390/v17050612pubmed: 40431624google scholar: lookup
            4. Rakowska A, Marciniak-Karcz A, Bereznowski A, Cywińska A, Żychska M, Witkowski L. Less Typical Courses of Rhodococcus equi Infections in Foals. Vet Sci 2022 Oct 31;9(11).
              doi: 10.3390/vetsci9110605pubmed: 36356082google scholar: lookup
            5. Badr C, Souiai O, Arbi M, El Behi I, Essaied MS, Khosrof I, Benkahla A, Chabchoub A, Ghram A. Epidemiological and Phylogeographic Study of Equid Herpesviruses in Tunisia. Pathogens 2022 Sep 5;11(9).
              doi: 10.3390/pathogens11091016pubmed: 36145448google scholar: lookup
            6. Wondimagegnehu K, Leta S, Amenu K, Negussie H. Molecular detection and assessment of the epidemiological risk factors associated with equine herpesvirus 2 and 5 in working equids in central Ethiopia. Vet Med Sci 2022 Nov;8(6):2396-2403.
              doi: 10.1002/vms3.925pubmed: 36063540google scholar: lookup
            7. Onasanya AE, El-Hage C, Diaz-Méndez A, Vaz PK, Legione AR, Browning GF, Devlin JM, Hartley CA. Whole genome sequence analysis of equid gammaherpesvirus -2 field isolates reveals high levels of genomic diversity and recombination. BMC Genomics 2022 Aug 30;23(1):622.
              doi: 10.1186/s12864-022-08789-xpubmed: 36042397google scholar: lookup
            8. Stasiak K, Dunowska M, Rola J. Kinetics of the Equid Herpesvirus 2 and 5 Infections among Mares and Foals from Three Polish National Studs. Viruses 2022 Mar 29;14(4).
              doi: 10.3390/v14040713pubmed: 35458443google scholar: lookup
            9. Temesgen T, Getachew Y, Negussie H. Molecular Identification of Equine Herpesvirus 1, 2, and 5 in Equids with Signs of Respiratory Disease in Central Ethiopia. Vet Med (Auckl) 2021;12:337-345.
              doi: 10.2147/VMRR.S339042pubmed: 34956854google scholar: lookup
            10. El-Hage C, Mekuria Z, Dynon K, Hartley C, McBride K, Gilkerson J. Association of Equine Herpesvirus 5 with Mild Respiratory Disease in a Survey of EHV1, -2, -4 and -5 in 407 Australian Horses. Animals (Basel) 2021 Nov 30;11(12).
              doi: 10.3390/ani11123418pubmed: 34944194google scholar: lookup
            11. Tsai MS, Newman C, Macdonald DW, Buesching CD. Stress-Related Herpesvirus Reactivation in Badgers Can Result in Clostridium Proliferation. Ecohealth 2021 Dec;18(4):440-450.
              doi: 10.1007/s10393-021-01568-2pubmed: 34870778google scholar: lookup
            12. Tsai MS, François S, Newman C, Macdonald DW, Buesching CD. Patterns of Genital Tract Mustelid Gammaherpesvirus 1 (Musghv-1) Reactivation Are Linked to Stressors in European Badgers (Meles Meles). Biomolecules 2021 May 11;11(5).
              doi: 10.3390/biom11050716pubmed: 34064759google scholar: lookup
            13. Thorsteinsdóttir L, Jónsdóttir S, Stefánsdóttir SB, Andrésdóttir V, Wagner B, Marti E, Torsteinsdóttir S, Svansson V. The effect of maternal immunity on the equine gammaherpesvirus type 2 and 5 viral load and antibody response. PLoS One 2019;14(6):e0218576.
              doi: 10.1371/journal.pone.0218576pubmed: 31226153google scholar: lookup
            14. Dall Agnol AM, Beuttemmuller EA, Pilz D, Leme RA, Saporiti V, Headley SA, Alfieri AF, Alfieri AA. Detection of Equid gammaherpesvirus 2 and 5 DNA in the upper respiratory tract of asymptomatic horses from Southern Brazil. Braz J Microbiol 2019 Jul;50(3):875-878.
              doi: 10.1007/s42770-019-00100-7pubmed: 31187445google scholar: lookup
            15. Azab W, Bedair S, Abdelgawad A, Eschke K, Farag GK, Abdel-Raheim A, Greenwood AD, Osterrieder N, Ali AAH. Detection of equid herpesviruses among different Arabian horse populations in Egypt. Vet Med Sci 2019 Aug;5(3):361-371.
              doi: 10.1002/vms3.176pubmed: 31149784google scholar: lookup
            16. Muscat KE, Padalino B, Hartley CA, Ficorilli N, Celi P, Knight P, Raidal S, Gilkerson JR, Muscatello G. Equine Transport and Changes in Equid Herpesvirus' Status. Front Vet Sci 2018;5:224.
              doi: 10.3389/fvets.2018.00224pubmed: 30320126google scholar: lookup
            17. Marenzoni ML, Stefanetti V, Danzetta ML, Timoney PJ. Gammaherpesvirus infections in equids: a review. Vet Med (Auckl) 2015;6:91-101.
              doi: 10.2147/VMRR.S39473pubmed: 30155436google scholar: lookup
            18. Stasiak K, Dunowska M, Rola J. Prevalence and sequence analysis of equid herpesviruses from the respiratory tract of Polish horses. Virol J 2018 Jul 11;15(1):106.
              doi: 10.1186/s12985-018-1018-3pubmed: 29996858google scholar: lookup
            19. Marenzoni ML, Bietta A, Lepri E, Casagrande Proietti P, Cordioli P, Canelli E, Stefanetti V, Coletti M, Timoney PJ, Passamonti F. Role of equine herpesviruses as co-infecting agents in cases of abortion, placental disease and neonatal foal mortality. Vet Res Commun 2013 Dec;37(4):311-7.
              doi: 10.1007/s11259-013-9578-6pubmed: 24052369google scholar: lookup
            20. Venn-Watson S, Benham C, Gulland FM, Smith CR, St Leger J, Yochem P, Nollens H, Blas-Machado U, Saliki J, Colegrove K, Wellehan JF Jr, Rivera R. Clinical relevance of novel Otarine herpesvirus-3 in California sea lions (Zalophus californianus): lymphoma, esophageal ulcers, and strandings. Vet Res 2012 Dec 12;43(1):85.
              doi: 10.1186/1297-9716-43-85pubmed: 23234600google scholar: lookup
            21. Shewen PE, Carrasco-Medina L, McBey BA, Hodgins DC. Challenges in mucosal vaccination of cattle. Vet Immunol Immunopathol 2009 Mar 15;128(1-3):192-8.
              doi: 10.1016/j.vetimm.2008.10.297pubmed: 19046777google scholar: lookup
            22. Giguère S, Hernandez J, Gaskin J, Prescott JF, Takai S, Miller C. Performance of five serological assays for diagnosis of Rhodococcus equi pneumonia in foals. Clin Diagn Lab Immunol 2003 Mar;10(2):241-5.
            23. Hu KF, Elvander M, Merza M, Akerblom L, Brandenburg A, Morein B. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses. Clin Exp Immunol 1998 Aug;113(2):235-43.